~~<i id='F66BAA8E03'><strike id='F66BAA8E03'><tt id='F66BAA8E03'><pre id='F66BAA8E03'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

Wikipedia

author：Wikipedia 2025-10-04 07:15:37 - browse：4

The Roche booth at ESMO in Madrid. — Roche's booth at the 2023 ESMO conference. Andrew Joseph/STAT

MADRID — A Roche drug lowered the risk of recurrence or death by 76% versus chemotherapy for patients with a type of early non-small cell lung cancer, according to data from a Phase 3 trial presented Saturday.

The findings, which Roche is planning to submit to regulators, could give patients with early-stage ALK-positive cancers another option. The standard treatment after surgery for these patients is chemotherapy.

The results from the Alina trial were presented here at the annual meeting of the European Society for Medical Oncology.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Senate panel to vote on hospitals, PBMs, prisoner care

focus

leisure time

hotspot

leisure time

knowledge

hotspot

EssayauthorMaraBuchbinderandherhusband,Jesse(right).CourtesyMaraBuchbinderMyhusband’scancercamebackt

WSS

House looks to weaken Medicare negotiation

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Telehealth options flood the market as retailers push virtual care

Telehealth options flood the market as retailers push virtual care

How to address the problem of discarded donor organs

Maker of FluMist seeks to allow at

entertainment

Wikipedia

focus

How one medical school became remarkably diverse

Eli Lilly to pay $200M for Beam’s stake in gene

Peter Hotez and the public health issue of online harassment

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

ChatGPT in medicine: STAT answers readers' burning questions

The pink breast cancer awareness ribbon needs a redesign

What does generative AI mean for health care? We asked experts

House looks to weaken Medicare negotiation

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

leisure time

Chimpanzees, like humans and whales, get menopause: Study

International team creates first chimeric human

WHO may add ‘noma' to its list of neglected tropical diseases

Congress gives doctors Medicare pay bump

An inside look at PIPEs, biotech's buzzy new financing tool

Covid isolation guidance eased by the CDC

hotspot

leisure time

knowledge

hotspot